
Robin Feldman on Drugs, Money, and Secret Handshakes
EconTalk
00:00
The Pharmaceutical Profit Paradox
This chapter explores the tension between necessary pharmaceutical innovation and the escalating costs tied to drug development. It critiques the practice of secondary patenting, where minor adjustments prolong monopolies without delivering significant advancements, affecting drug pricing and access. The discussion culminates in a call for a reevaluation of the current patent system to prioritize true innovations over profit-driven tactics.
Transcript
Play full episode